Isabel Lambertz

486 citations
15 papers · 389 indexed · h-index 10
Topics
Cancer Cells and Metastasis (5 papers)Growth Hormone and Insulin-like Growth Factors (4 papers)Cancer-related Molecular Pathways (4 papers)

In The Last Decade

Isabel Lambertz

14 papers receiving 381 citations

Peers

Isabel Lambertz
Comparison fields: 5 of 67
  • Molecular Biology 251
  • Cancer Research 143
  • Oncology 136
  • Genetics 68
  • Endocrinology, Diabetes and Metabolism 42
Replace Latoya E. Campbell with:
Latoya E. Campbell United States
Sylwia Grodecka-Gazdecka Poland
Lei‐Ya Fang Taiwan
Anke Neuwirth United States
Yue Xue China
Christopher Hillard United States
Laure Maneix United States
Verónica García-Carpizo Spain
Isabel Lambertz relative to Latoya E. Campbell United States Latoya E. Campbell's profile →
Citations per field
00.5×3.3×
Latoya E. Campbell · 1×
Citations per year

Countries citing papers authored by Isabel Lambertz

Since Specialization
Citations

This map shows the geographic impact of Isabel Lambertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Lambertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Lambertz more than expected).

Fields of papers citing papers by Isabel Lambertz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Lambertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Lambertz. The network helps show where Isabel Lambertz may publish in the future.

Co-authorship network of co-authors of Isabel Lambertz

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Lambertz. A scholar is included among the top collaborators of Isabel Lambertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Lambertz. Isabel Lambertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 4
2 9
3 12
4 11
5 1
6 28
7 13
8 20
9 85
10 125
11 57
12 7
13 2
14 5
15 10

About Isabel Lambertz

Isabel Lambertz is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Virology, having authored 15 papers that have together received 389 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (143 citations), Oncology (136 citations) and Molecular Biology (251 citations). Isabel Lambertz has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Robin Fuchs‐Young, Jie Tian, Joyce E. Rundhaug, Stephanie H. Shirley, Michael A. Dyer, Geertrui Denecker, Jean‐Christophe Marine, Jo Vandesompele, David Nittner and Pieter Mestdagh. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026